Literature DB >> 28838961

Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.

Robert Jablonowski1, Uzma Chaudhry1, Jesper van der Pals1, Henrik Engblom1, Håkan Arheden1, Einar Heiberg1, Katherine C Wu1, Rasmus Borgquist1, Marcus Carlsson2.   

Abstract

BACKGROUND: Late gadolinium enhancement (LGE) border zone on cardiac magnetic resonance imaging has been proposed as an independent predictor of ventricular arrhythmias. The purpose was to determine whether size and heterogeneity of LGE predict appropriate implantable cardioverter defibrillator (ICD) therapy in ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM) patients and to evaluate 4 LGE border-zone algorithms. METHODS AND
RESULTS: ICM and NICM patients who underwent LGE cardiac magnetic resonance imaging prior to ICD implantation were retrospectively included. Two semiautomatic algorithms, expectation maximization, weighted intensity, a priori information and a weighted border zone algorithm, were compared with a modified full-width half-maximum and a 2-3SD threshold-based algorithm (2-3SD). Hazard ratios were calculated per 1% increase in LGE. A total of 74 ICM and 34 NICM were followed for 63 months (1-140) and 52 months (0-133), respectively. ICM patients had 27 appropriate ICD events, and NICM patients had 7 ICD events. In ICM patients with primary prophylactic ICD, LGE border zone predicted ICD therapy in univariable and multivariable analysis measured by the expectation maximization, weighted intensity, a priori information, weighted border zone, and modified full-width half-maximum algorithms (hazard ratios 1.23, 1.22, and 1.05, respectively; P<0.05; negative predictive value 92%). For NICM, total LGE by all 4 methods was the strongest predictor (hazard ratios, 1.03-1.04; P<0.05), though the number of events was small.
CONCLUSIONS: Appropriate ICD therapy can be predicted in ICM patients with primary prevention ICD by quantifying the LGE border zone. In NICM patients, total LGE but not LGE border zone had predictive value for ICD therapy. However, the algorithms used affects the predictive value of these measures.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cardiac magnetic resonance imaging; implanted cardioverter defibrillator; ischemic cardiomyopathy; late gadolinium enhancement; nonischemic cardiomyopathy

Mesh:

Substances:

Year:  2017        PMID: 28838961      PMCID: PMC5580266          DOI: 10.1161/CIRCIMAGING.116.006105

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  34 in total

1.  Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

Authors:  Stijntje D Roes; C Jan Willem Borleffs; Rob J van der Geest; Jos J M Westenberg; Nina Ajmone Marsan; Theodorus A M Kaandorp; Johan H C Reiber; Katja Zeppenfeld; Hildo J Lamb; Albert de Roos; Martin J Schalij; Jeroen J Bax
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-23       Impact factor: 7.792

2.  Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.

Authors:  Sebastiaan R D Piers; Kimberly Everaerts; Rob J van der Geest; Mark R Hazebroek; Hans-Marc Siebelink; Laurent A F G Pison; Martin J Schalij; Sebastiaan C A M Bekkers; Stephane Heymans; Katja Zeppenfeld
Journal:  Heart Rhythm       Date:  2015-05-22       Impact factor: 6.343

3.  A standardized definition of ischemic cardiomyopathy for use in clinical research.

Authors:  G Michael Felker; Linda K Shaw; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

5.  Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Authors:  Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

6.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

7.  Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  Eri Watanabe; Siddique A Abbasi; Bobak Heydari; Otavio R Coelho-Filho; Ravi Shah; Tomas G Neilan; Venkatesh L Murthy; François-Pierre Mongeon; Chirag Barbhaiya; Michael Jerosch-Herold; Ron Blankstein; Hiroto Hatabu; Robert J van der Geest; William G Stevenson; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2014-10-06       Impact factor: 7.792

8.  Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study.

Authors:  Einar Heiberg; Martin Ugander; Henrik Engblom; Matthias Götberg; Göran K Olivecrona; David Erlinge; Håkan Arheden
Journal:  Radiology       Date:  2007-11-30       Impact factor: 11.105

9.  Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.

Authors:  Hussein Rayatzadeh; Alex Tan; Raymond H Chan; Shalin J Patel; Thomas H Hauser; Long Ngo; Jaime L Shaw; Susie N Hong; Peter Zimetbaum; Alfred E Buxton; Mark E Josephson; Warren J Manning; Reza Nezafat
Journal:  J Cardiovasc Magn Reson       Date:  2013-04-10       Impact factor: 5.364

10.  A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data.

Authors:  Henrik Engblom; Jane Tufvesson; Robert Jablonowski; Marcus Carlsson; Anthony H Aletras; Pavel Hoffmann; Alexis Jacquier; Frank Kober; Bernhard Metzler; David Erlinge; Dan Atar; Håkan Arheden; Einar Heiberg
Journal:  J Cardiovasc Magn Reson       Date:  2016-05-04       Impact factor: 5.364

View more
  9 in total

Review 1.  Recent Advances in Fibrosis and Scar Segmentation From Cardiac MRI: A State-of-the-Art Review and Future Perspectives.

Authors:  Yinzhe Wu; Zeyu Tang; Binghuan Li; David Firmin; Guang Yang
Journal:  Front Physiol       Date:  2021-08-03       Impact factor: 4.566

Review 2.  Risk stratification for sudden cardiac death in patients with heart failure : Emerging role of imaging parameters.

Authors:  Ikram Kammoun; Emna Bennour; Lobna Laroussi; Manel Miled; Ahmed Sghaier; Karmous Rahma; Boussema Amine; Sonia Marrakchi; Salem Kachboura
Journal:  Herz       Date:  2021-04-28       Impact factor: 1.443

Review 3.  Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death.

Authors:  Giorgio Faganello; Aldostefano Porcari; Federico Biondi; Marco Merlo; Antonio De Luca; Giancarlo Vitrella; Manuel Belgrano; Lorenzo Pagnan; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  J Cardiovasc Echogr       Date:  2019 Jul-Sep

4.  Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy.

Authors:  Gabriel Balaban; Brian P Halliday; Bradley Porter; Wenjia Bai; Ståle Nygåard; Ruth Owen; Suzan Hatipoglu; Nuno Dias Ferreira; Cemil Izgi; Upasana Tayal; Ben Corden; James Ware; Dudley J Pennell; Daniel Rueckert; Gernot Plank; Christopher A Rinaldi; Sanjay K Prasad; Martin J Bishop
Journal:  JACC Clin Electrophysiol       Date:  2020-10-29

Review 5.  The Role of AI in Characterizing the DCM Phenotype.

Authors:  Clint Asher; Esther Puyol-Antón; Maleeha Rizvi; Bram Ruijsink; Amedeo Chiribiri; Reza Razavi; Gerry Carr-White
Journal:  Front Cardiovasc Med       Date:  2021-12-21

6.  Anatomically informed deep learning on contrast-enhanced cardiac magnetic resonance imaging for scar segmentation and clinical feature extraction.

Authors:  Dan M Popescu; Haley G Abramson; Rebecca Yu; Changxin Lai; Julie K Shade; Katherine C Wu; Mauro Maggioni; Natalia A Trayanova
Journal:  Cardiovasc Digit Health J       Date:  2021-11-26

7.  Improving Clinical Translation of Machine Learning Approaches Through Clinician-Tailored Visual Displays of Black Box Algorithms: Development and Validation.

Authors:  Shannon Wongvibulsin; Katherine C Wu; Scott L Zeger
Journal:  JMIR Med Inform       Date:  2020-06-09

8.  Time-efficient three-dimensional transmural scar assessment provides relevant substrate characterization for ventricular tachycardia features and long-term recurrences in ischemic cardiomyopathy.

Authors:  Susana Merino-Caviedes; Lilian K Gutierrez; José Manuel Alfonso-Almazán; Santiago Sanz-Estébanez; Lucilio Cordero-Grande; Jorge G Quintanilla; Javier Sánchez-González; Manuel Marina-Breysse; Carlos Galán-Arriola; Daniel Enríquez-Vázquez; Carlos Torres; Gonzalo Pizarro; Borja Ibáñez; Rafael Peinado; Jose Luis Merino; Julián Pérez-Villacastín; José Jalife; Mariña López-Yunta; Mariano Vázquez; Jazmín Aguado-Sierra; Juan José González-Ferrer; Nicasio Pérez-Castellano; Marcos Martín-Fernández; Carlos Alberola-López; David Filgueiras-Rama
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

Review 9.  Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death.

Authors:  Maria Delia Corbo; Enrica Vitale; Maurizio Pesolo; Grazia Casavecchia; Matteo Gravina; Pierluigi Pellegrino; Natale Daniele Brunetti; Massimo Iacoviello
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.